Previous 10 | Next 10 |
Without education, we are in a horrible and deadly danger of taking educated people seriously. "― G.K. Chesterton Today, we revisit a name we have covered often over the past two years. The company has been maddening for investors as the shares trade at the same level as a year ago...
Biopharma Dynavax Technologies (NASDAQ: DVAX) is one of many companies racing to develop a COVID-19 vaccine. Like many coronavirus-focused companies, Dynavax has seen its shares rise on the ongoing concern related to the pandemic -- in its case, by 50% year to date. While investors may co...
The following slide deck was published by Omeros Corporation in conjunction with this Read more ...
Omeros Corporation (Nasdaq: OMER) today announced that the results of its pivotal trial of narsoplimab in the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy (HSCT-TMA) were shared during an oral presentation at the virtual edition of the 25th Congress o...
Omeros Corporation (Nasdaq: OMER): The results of Omeros’ pivotal trial of narsoplimab for the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy (HSCT-TMA) will be shared as an oral presentation at the virtual edition of the 25th annual European Hema...
"Nothing strengthens authority so much as silence .”― Leonardo da Vinci Today, we are circling back and revisiting the investment case on Omeros ( OMER ) after this ' Tier 3 ' concern posted quarterly results on Tuesday. Like so many biotech/biopharma names, sales from ...
Omeros Corporation (Nasdaq: OMER) today announced that the results of its pivotal trial of narsoplimab in the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy will be presented at the 25 th Annual Congress of the European Hematology Association (EHA) to b...
Image source: The Motley Fool. Omeros (NASDAQ: OMER) Q1 2020 Earnings Call May 11, 2020 , 4:30 p.m. ET Operator Continue reading
Omeros Corporation (OMER) Q1 2020 Earnings Conference Call May 11, 2020 4:30 PM ET Company Participants Jennifer Williams – Investor Relations Greg Demopulos – Chairman and Chief Executive Officer Mike Jacobsen – Chief Accounting Officer Conference Call Pa...
Omeros (NASDAQ: OMER ): Q1 Non-GAAP EPS of -$0.41 misses by $0.07 ; GAAP EPS of -$0.53 misses by $0.19 . Revenue of $23.5M (+7.9% Y/Y) misses by $6.71M . Press Release More news on: Omeros Corporation, Earnings news and commentary, Healthcare stocks news,
News, Short Squeeze, Breakout and More Instantly...
2024-07-18 09:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
$118.1 million, or 55%, of outstanding convertible notes due in 2026 repurchased at approximately 75% of notional value, resulting in $51 million in total debt extinguishment Repurchase funded from new $67 million secured four-year term loan maturing in June 2028 together with $21 million...
A look at the top 10 most actives in the United States Crown Electrokinetics Corp. (CRKN) rose 419.5% to $0.24 on volume of 2,920,436,648 shares Greenwave Technology Solutions Inc. (GWAV) rose 147.7% to $0.1481 on volume of 1,864,631,229 shares Faraday Future Intelligent Electric Inc. (FF...